<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> developed in a patient after administration of <z:chebi fb="1" ids="8711">quinacrine</z:chebi> for treatment of <z:hpo ids='HP_0007417'>discoid lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Marrow transplantation was performed from an HLA genotypically identical sister after conditioning with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="1" ids="8711">Quinacrine</z:chebi> which was accumulated in the patient tissues did not interfere with engraftment, suggesting that the drug has no direct cytotoxic effect on hematopoietic stem cells </plain></SENT>
<SENT sid="3" pm="."><plain>This study extends our previous observation that severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> acquired after exposure to drugs or toxins can be cured by marrow transplantation </plain></SENT>
</text></document>